Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei Lou

Showing results (171-180 of 182) with videos related to

Pageof 19
Sort By:
Oncogene|July 17, 2021
ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signalingChengfei Liu, Cameron M Armstrong, Shu Ning, et al.
Plos One|April 6, 2012
MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growthNagalakshmi Nadiminty, Ramakumar Tummala, Wei Lou, et al.
Molecular Cancer Therapeutics|December 5, 2025
IGFBP3-SphK1/S1P Signaling Axis Drives Enzalutamide Resistance in Advanced Prostate CancerAmy R Leslie, Shu Ning, Masuda Sharifi, et al.
Nature Communications|November 18, 2018
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancerChengfei Liu, Wei Lou, Joy C Yang, et al.
Molecular Cancer Therapeutics|May 5, 2026
Targeting NDUFS4 Disrupts Oxidative Phosphorylation and Induces Ferroptosis in Olaparib-Resistant Prostate CancerZachary A Schaaf, Shu Ning, Amy R Leslie, et al.
Molecular Cancer Therapeutics|April 9, 2026
Targeting NDUFS4 Disrupts Oxidative Phosphorylation and Induces Ferroptosis in Olaparib-Resistant Prostate CancerZachary A Schaaf, Shu Ning, Amy R Leslie, et al.
Parasites & Vectors|January 12, 2023
Interactions between the gut micro-community and transcriptome of Culex pipiens pallens under low-temperature stressWen-Xiang Lv, Peng Cheng, Jing-Jing Lei, et al.
Diagnostic Pathology|September 7, 2024
Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic reviewYou-Yuan Su, Ya-Fei Yu, Zhen-Yu Yan, et al.
Communications Medicine|September 26, 2022
Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomesShu Ning, Jinge Zhao, Alan P Lombard, et al.
Cancer Research|August 1, 2024
LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer TherapyShu Ning, Cameron M Armstrong, Enming Xing, et al.
Pageof 19

Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
Oncogene|July 17, 2021
ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signalingChengfei Liu, Cameron M Armstrong, Shu Ning, et al.
Plos One|April 6, 2012
MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growthNagalakshmi Nadiminty, Ramakumar Tummala, Wei Lou, et al.
Molecular Cancer Therapeutics|December 5, 2025
IGFBP3-SphK1/S1P Signaling Axis Drives Enzalutamide Resistance in Advanced Prostate CancerAmy R Leslie, Shu Ning, Masuda Sharifi, et al.
Nature Communications|November 18, 2018
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancerChengfei Liu, Wei Lou, Joy C Yang, et al.
Molecular Cancer Therapeutics|May 5, 2026
Targeting NDUFS4 Disrupts Oxidative Phosphorylation and Induces Ferroptosis in Olaparib-Resistant Prostate CancerZachary A Schaaf, Shu Ning, Amy R Leslie, et al.
Molecular Cancer Therapeutics|April 9, 2026
Targeting NDUFS4 Disrupts Oxidative Phosphorylation and Induces Ferroptosis in Olaparib-Resistant Prostate CancerZachary A Schaaf, Shu Ning, Amy R Leslie, et al.
Parasites & Vectors|January 12, 2023
Interactions between the gut micro-community and transcriptome of Culex pipiens pallens under low-temperature stressWen-Xiang Lv, Peng Cheng, Jing-Jing Lei, et al.
Diagnostic Pathology|September 7, 2024
Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic reviewYou-Yuan Su, Ya-Fei Yu, Zhen-Yu Yan, et al.
Communications Medicine|September 26, 2022
Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomesShu Ning, Jinge Zhao, Alan P Lombard, et al.
Cancer Research|August 1, 2024
LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer TherapyShu Ning, Cameron M Armstrong, Enming Xing, et al.
Pageof 19